NCT03306173

Brief Summary

Early attempts by the tobacco industry to develop "safer" cigarettes led to the widespread introduction of ventilation holes in cigarette filters; however, this design feature may instead increase smoking-related harm and make cigarettes more palatable. The overall goal of this project is to model regulatory restrictions banning cigarette filter ventilation and determine their effects on consumption of both cigarettes and a wide range of alternative tobacco products. Testing potential regulatory actions under controlled conditions will facilitate evidence-based policies that have a net benefit to health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
142

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 10, 2017

Completed
10 months until next milestone

Study Start

First participant enrolled

August 8, 2018

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2020

Completed
5.6 years until next milestone

Results Posted

Study results publicly available

October 7, 2025

Completed
Last Updated

October 7, 2025

Status Verified

September 1, 2025

Enrollment Period

1.6 years

First QC Date

September 29, 2017

Results QC Date

June 12, 2025

Last Update Submit

September 17, 2025

Conditions

Outcome Measures

Primary Outcomes (8)

  • High Ventilated Cigarette Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of their assigned cigarette increased progressively from $0.13 in the first trial to $4.00 in the final trial, while prices for other products (e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial were calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

  • Low Ventilated Cigarette Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of High Ventilated Cigarettes (HVC) increased progressively from $0.13 in the first trial to $4.00 in the final trial foe ventilated cigarette users and Low Ventilated Cigarettes (LVC) increased progressively from $0.13 in the first trial to $4.00 for the unventilated group, while prices for other products (Low Ventilated Cigarettes (LVC), e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial was calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

  • E-Cigarette Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of High Ventilated Cigarettes (HVC) increased progressively from $0.13 in the first trial to $4.00 in the final trial for ventilated cigarette users and Low Ventilated Cigarettes (LVC) increased progressively from $0.13 in the first trial to $4.00 for the unventilated group, while prices for other products (Low Ventilated Cigarettes (LVC), e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial was calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

  • E-liquid Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of High Ventilated Cigarettes (HVC) increased progressively from $0.13 in the first trial to $4.00 in the final trial foe ventilated cigarette users and Low Ventilated Cigarettes (LVC) increased progressively from $0.13 in the first trial to $4.00 for the unventilated group, while prices for other products (Low Ventilated Cigarettes (LVC), e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial was calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

  • Gum Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of High Ventilated Cigarettes (HVC) increased progressively from $0.13 in the first trial to $4.00 in the final trial foe ventilated cigarette users and Low Ventilated Cigarettes (LVC) increased progressively from $0.13 in the first trial to $4.00 for the unventilated group, while prices for other products (Low Ventilated Cigarettes (LVC), e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial was calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

  • Snus Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of High Ventilated Cigarettes (HVC) increased progressively from $0.13 in the first trial to $4.00 in the final trial foe ventilated cigarette users and Low Ventilated Cigarettes (LVC) increased progressively from $0.13 in the first trial to $4.00 for the unventilated group, while prices for other products (Low Ventilated Cigarettes (LVC), e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial was calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

  • Lozenge Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of High Ventilated Cigarettes (HVC) increased progressively from $0.13 in the first trial to $4.00 in the final trial foe ventilated cigarette users and Low Ventilated Cigarettes (LVC) increased progressively from $0.13 in the first trial to $4.00 for the unventilated group, while prices for other products (Low Ventilated Cigarettes (LVC), e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial was calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

  • Dip Purchases

    Participants completed purchasing trials in an experimental marketplace, a virtual store designed to mimic real-world shopping environments. In each lab session, participants completed multiple trials in which the price of High Ventilated Cigarettes (HVC) increased progressively from $0.13 in the first trial to $4.00 in the final trial foe ventilated cigarette users and Low Ventilated Cigarettes (LVC) increased progressively from $0.13 in the first trial to $4.00 for the unventilated group, while prices for other products (Low Ventilated Cigarettes (LVC), e-cigarettes, e-liquid, nicotine gum, snus, lozenges, and dip) remained constant. The mean and standard deviation of quantity purchased in each trial was calculated for all prices and sessions 1, 2, and 3.

    Week 2 (Session 1), Week 6 (Sessions 2), Week 10 (Session 3)

Study Arms (2)

Ventilated cigarettes

EXPERIMENTAL

Participants in this ARM will be assigned to \~25% filter ventilation commercially available cigarettes.

Other: Commercially available cigarette

Unventilated cigarettes

EXPERIMENTAL

Participants in this ARM will be assigned to \~0% filter ventilation commercially available cigarettes.

Other: Commercially available cigarette

Interventions

Commercially available cigarette with either \~0% or \~25% filter ventilation. Menthol flavor will be available in both types.

Unventilated cigarettesVentilated cigarettes

Eligibility Criteria

Age21 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Current cigarette smoker
  • Stable mental and physical health
  • Does not take medications that interfere with nicotine metabolism

You may not qualify if:

  • Pregnant or lactating
  • Immediate future plans to quit smoking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fralin Biomedical Research Institute at VTC

Roanoke, Virginia, 24016, United States

Location

MeSH Terms

Conditions

Substance-Related Disorders

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental Disorders

Limitations and Caveats

During the study, the researchers detected changes in the ventilation levels of the low-ventilated study cigarettes introduced by the manufacturer, which may have altered the intended intervention and results.

Results Point of Contact

Title
Dr. Roberta Freitas-Lemos
Organization
Fralin Biomedical Research Institute at VTC

Study Officials

  • Warren K Bickel, PHD

    Fralin Biomedical Research Institute at VTC

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Participants will be randomly assigned to either ventilated or unventilated cigarettes and will not be informed of their group assignment.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Participants will be assigned to either use a ventilated or unventilated cigarette.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 29, 2017

First Posted

October 10, 2017

Study Start

August 8, 2018

Primary Completion

March 10, 2020

Study Completion

March 10, 2020

Last Updated

October 7, 2025

Results First Posted

October 7, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will share

Results from research conducted under this project will be disseminated in several ways. Findings will be presented at national conferences for groups such as the Society for Research on Nicotine and Tobacco (SRNT) and the College on Problems of Drug Dependence (CPDD). Manuscripts will be written and submitted for publication in a timely manner in high-quality peer-reviewed journals, following the NIH Public Access Policy guidelines.

Time Frame
Data will be made available upon request after dissemination of results.
Access Criteria
Data requests will be reviewed by the principal investigator and data will be shared with the expectation of acknowledgment of funding source and primary study team.

Locations